期刊文献+

吡柔比星膀胱灌注预防膀胱肿瘤复发 被引量:11

Pirarubicin bladder irrigation prevent recurrence of bladder tumor
下载PDF
导出
摘要 目的探讨浅表性膀胱癌术后采用吡柔比星(THP)膀胱灌注预防肿瘤复发的临床效果。方法对38例浅表性膀胱癌患者自术后第1周起用吡柔比星30 mg膀胱灌注,隔日1次,共6次;之后改为2周1次,共4次;4周1次,共4次;8周1次,持续至1 a。随访6个月~2 a,观察肿瘤复发率和不良反应情况。结果术后1 a内无肿瘤复发,1 a后肿瘤复发3例(8%)。21例(55%)出现尿频、尿急、尿痛、血尿和膀胱区疼痛;无须治疗,5 d后症状消失;6例(11%)出现严重的膀胱痉挛,给予托特罗定和/或灌注时加利多卡因症状消失;2例(5%)膀胱挛缩而中断灌注,给予托特罗定、膀胱训练治愈;2例(5%)出现尿道狭窄,给予定期尿道扩张排尿通畅。结论THP膀胱灌注预防膀胱肿瘤复发疗效显著,但要积极预防和处理并发症。 Objective It is to approach the prevention effect of bladder tumor recurrence by Pirarubicin bladder irrigation in superficial bladder cancer postoperative.Methods Since the first week postoperative,38 patients with superficial bladder cancer were treated with Pirarubicin 30 mg by bladder instillation,until 1 year.Followed up 6 months to 2 years,the tumor recurrence rate and side effect were observed.Results There was on recurrence within one year,3 cases(8%) recurred after one year.21 cases(55%) showed up symptoms such as frequent micturition,urgency,urination pain,hematuria and bladder pain,and the symptoms disappeared in 5 days without treatment.6 cases(11%) with severe bladder spasticity treated with tolterodine and/or add lidocaine in perfusion.2 cases(5%) of bladder contracture and perfusion interrupted treated with tolterodine and bladder training for curable.2 cases(5%) of urethral stricture were given regular urethral smooth expansion.Conclusion The effect of Pirarubicin bladder irrigation to prevent bladder tumor recurrence was significant,but to actively prevent and deal with complications.
出处 《现代中西医结合杂志》 CAS 2010年第21期2610-2611,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 膀胱肿瘤 膀胱灌注 并发症 吡柔比星 bladder tumor bladder irrigation complication Pirarubicin
  • 相关文献

参考文献9

  • 1Lamm DL.Prophylaxis for recurrent transitional cell carcinoma[J].Urology,1991,37(Suppl 5):21.
  • 2Nakagawa S,Kojima M,Takada H,et al.Short-duration bladder instillation therapy with pirarubicin for superficial bladder tumor based on pharmacodynamic study[J].Gan To Kagaku Ryoho,1992,19(11):1873.
  • 3Kobayashi M,Sugaya Y,Yuzawa M,et al.Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue,anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor[J].Gan To Kagaku Ryoho,1998,25(11):1771.
  • 4孙宏斌,刘军,苏江浩,沈明顺,贾瑞鹏.吡柔比星膀胱灌注预防浅表性膀胱癌术后复发[J].临床泌尿外科杂志,2002,17(6):284-285. 被引量:43
  • 5Okamura K,Ono Y,Kinukawa T,et al.Randomized study of single early instillation of (2″R)-4′-O-tetrahy-dropyranyl-doxorubicin for a single superficial bladder carcinoma[J].Cancer,2002,94(9):2363.
  • 6]Kuroda K,Lshii N,Fukasawa K,et al.Short term intravesical instillation of pirarubicin (THP) in prophylaticc treatment after transurethral resection of superficial bladder tumor[J].I Hinyokika Kiyo,1998,44(8):547.
  • 7Richie JP.Intravesical chemothetopy:Treatment selection,techni ques,and results[J].UCNA,1992,19(3):523.
  • 8Aikawa K,Lrisawa C,Mwraki O,et al.Postoperative intravesical instillation of THP for superficial bladder tumor:clinical results of prophylactic effect on the recurrence[J].Gan To Kagaku,1992,19(4):509.
  • 9黄永斌,徐华,胡永泉,李庆文.卡介苗膀胱灌注防治复发性膀胱肿瘤[J].蚌埠医学院学报,1992,17(2):115-116. 被引量:1

二级参考文献1

共引文献42

同被引文献52

引证文献11

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部